• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. ARTEMIS NEURO EVACUATION DEVICE; GWG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. ARTEMIS NEURO EVACUATION DEVICE; GWG Back to Search Results
Model Number AP28-A
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 03/02/2021
Type of Reportable Event Death
Additional Manufacturer Narrative
The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.Potential adverse events in the labeling with the artemis neuro evacuation device include, but are not limited to, hydrocephalus, hematoma or hemorrhage at the site, intraventricular hemorrhage, re-bleeding, thromboembolic events, including death.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Event or Problem Description
On (b)(6) 2021, the patient underwent a minimally invasive surgery (mis) procedure in the right parietal and occipital lobes using an artemis neuro evacuation device (artemis).The ultrasound during the procedure showed good evacuation of the hemorrhage, and no procedural complications were reported.The patient remained stable throughout the procedure and remained intubated and sedated while being transferred for a routine post-operative computed tomography (ct) scan of the head.The ct scan revealed a large re-hemorrhage at the same site with extension into the right ventricle.The patient was returned to the operating room (or) and underwent a right craniotomy, evacuation of the re-hemorrhage, and insertion of an external ventricular drain (evd).The patient was then transferred to the neurological critical care unit (nccu).On (b)(6) 2021, the patient demonstrated a worsening in his neurological examination.Immediately following this, the patient had a ct demonstrating new areas of hemorrhage and extensive edema lateral to the primary hemorrhage within the parietal lobe with marked associated midline shift.The patient was transferred to the or for another craniotomy and hemorrhage evacuation.Post-operative ct scan demonstrated further progression of the edema & hemorrhage far lateral to the region of the original hemorrhage and mis procedure.He was returned to the or for extension of his craniectomy with resection of some of the injured brain tissue.Post-op ct showed adequate decompression and reduced midline shift.Magnetic resonance (mr) imaging was completed 3/4 which showed the hemorrhage but no underlying mass.The magnetic resonance angiogram (mra) was reported to be normal.Magnetic resonance venography (mrv) showed patency of the major dural sinuses.Conventional angiography demonstrated an absence of cortical veins over the right parietal and occipital regions.There was no evidence of an arterial vascular lesion or vasculitis to account for this rapidly progressive multifocal hemorrhage and edema.On (b)(6) 2021, the patient could follow some simple commands and was extubated.On (b)(6) 2021, the patient failed to wean and was re-intubated.It was also reported that the patient¿s neurological status was unchanged.Family decided comfort care and the patient was terminally extubated on (b)(6) 2021.The re-hemorrhage and the new cerebral multifocal hemorrhage with edema leading to the patient's expiration were adjudicated to be serious adverse events with a probable relationship to the artemis and a definite relationship to the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTEMIS NEURO EVACUATION DEVICE
Common Device Name
GWG
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key12981477
Report Number3005168196-2021-02779
Device Sequence Number20054505
Product Code GWG
UDI-Device Identifier00814548017877
UDI-Public00814548017877
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K171332
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 12/10/2021
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/22/2021
Device Model NumberAP28-A
Device Catalogue NumberAP28
Device Lot NumberS10007
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/14/2021
Initial Report FDA Received Date12/10/2021
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured01/23/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Death; Required Intervention;
Patient Age77 YR
Patient SexMale
Date Report Sent to FDA01/01/2005
-
-